文献速递美容整形

透明质酸填充眶上凹陷的前瞻性队列研究:疗效与维持时间

Hyaluronic acid fillers for supraorbital hollowing: A prospective cohort study of efficacy and longevity.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2026-03-07

这项前瞻性单中心队列研究纳入46例轻中度眶上凹陷成人,经外侧入路用25G钝针行眶上骨膜上注射交联透明质酸(每眼睑0.2-0.4 mL)。6个月时医生与患者GAIS均较高,91%评为「很好」或「极好」,仅见一过性瘀斑和水肿,无严重并发症。

要点

  • 眶上骨膜上注射交联透明质酸可有效矫正眶上凹陷。
  • 6个月时医生与患者满意度均高,91%评为很好或极好。
  • 仅见一过性瘀斑和水肿,无严重并发症。

核心结论

  • 经外侧入路用钝针行眶上骨膜上注射透明质酸可重复地矫正眶上凹陷,6个月时满意度高且不良事件多为自限性。

研究设计与样本

  • 前瞻性单中心队列研究,纳入46例轻中度眶上凹陷成人,行眶上骨膜上注射交联透明质酸(每眼睑0.2-0.4 mL,Lorient No. 2),经外侧入路使用25G钝针。
  • 基线及6个月拍摄标准化照片,由两名互盲的 board-certified 医师基于照片独立评估GAIS,患者另行评估,并前瞻性记录不良事件。

主要发现

  • 所有患者完成6个月随访。
  • 医生GAIS均值为4.3 ± 0.5,患者GAIS均值为4.5 ± 0.6。
  • 91%被评为「很好」或「极好」。
  • 一过性瘀斑发生率为28%,水肿为26%,均无需干预自行消退。
  • 未发生严重并发症。

关键数值与推荐

  • GAIS评分范围1-5分。
  • 注射剂量为每眼睑0.2-0.4 mL交联透明质酸。
  • 使用25G钝针经外侧入路行眶上骨膜上注射。
  • 证据等级为IV级。

临床怎么用

  • 对轻中度眶上凹陷成人,可考虑经外侧入路用25G钝针行眶上骨膜上注射交联透明质酸(每眼睑0.2-0.4 mL)。
  • 术前应告知患者可能出现一过性瘀斑(28%)和水肿(26%),但多可自行消退。

局限性

  • 单中心、非对照队列设计,证据等级为IV级。
  • 随访时间仅6个月,未报告更长期维持时间数据。
  • 样本量为46例,规模有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Supraorbital hollowing from age-related volume loss or post-blepharoplasty overresection causes upper sulcus deflation. Hyaluronic acid (HA) fillers are frequently used in the upper eyelid, but prospective clinical follow-up data remain limited. METHODS: This prospective single-centre cohort study enroled 46 adults with mild-moderate supraorbital hollowing who underwent supraperiosteal injection of cross-linked hyaluronic acid (0.2-0.4 mL per eyelid, Lorient No. 2) using a 25G blunt cannula via a lateral entry point. Standardised photographs were obtained at baseline and 6 months. Global Aesthetic Improvement Scale (GAIS; 1-5) was independently assessed at 6 months by two board-certified physicians blinded to each other's ratings based on comparative photographic evaluation, and separately by patients. Adverse events were prospectively recorded. RESULTS: All patients completed 6-month follow-up. Mean physician GAIS was 4.3 ± 0.5 and mean patient GAIS was 4.5 ± 0.6; 91% were rated "very good" or "exceptional". Transient bruising (28%) and oedema (26%) resolved without intervention. No serious complications occurred. CONCLUSION: Deep supraperiosteal HA filler delivered by blunt cannula provided reproducible correction of supraorbital hollowing with high satisfaction and a low rate of self-limited adverse events at 6 months. LEVEL OF EVIDENCE: IV.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Yi KH, Koppert E, Fai WK, et al. Hyaluronic acid fillers for supraorbital hollowing: A prospective cohort study of efficacy and longevity. J Plast Reconstr Aesthet Surg. 2026. PMID: 41850033. doi:10.1016/j.bjps.2026.03.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。